# Ribonuclease 4 Functions in Nociceptor-Mediated Nerve Homeostasis

**Authors:** Xiaona Feng, Kaiwen Zhang, Prach Techameena, Rolen M. Quadros, Csaba Adori, Aliia Murtazina, Igor Adameyko, Sofia Biagini, Ozun Gokce Bayramlik, Francois Lallemend, Channabasavaiah B. Gurumurthy, Saida Hadjab

PMC · DOI: 10.1038/s41467-026-70365-8 · Nature Communications · 2026-03-24

## TL;DR

This study shows that ribonuclease 4 helps regulate pain-sensing nerve cells and supports nerve repair by maintaining nerve stability.

## Contribution

The study identifies RNase4 as a dual regulator of nociceptor function and myelin integrity.

## Key findings

- RNase4 is selectively expressed in unmyelinated nociceptors and regulates their function.
- RNase4 deletion alters mechanical sensation and affects myelin structure in adjacent axons.
- RNase4 expression increases during pain and recovery phases in a neuropathic model.

## Abstract

The regulation of nociceptor identity and function is essential, as disruptions can significantly influence pain sensation, yet our understanding of the molecular mechanisms involved remains incomplete. In this study, we identified ribonuclease 4 (RNase4) as selectively expressed in the unmyelinated nociceptor lineage. Analysis of RNase4-deficient mice and single-cell transcriptomic data revealed a cell-autonomous role for RNase4 in regulating nociceptor function. Moreover, in a neuropathic pain model, RNase4 expression was upregulated in nociceptors during the pain and recovery phases, and its deletion altered mechanical sensation. Additionally, RNase4 exerted non-cell- autonomous effects on the myelin structural organization of adjacent myelinated axons. Together, these findings implicate RNase4 as a dual regulator of nociceptor biology and myelin integrity, revealing a molecular pathway for pain regulation and nerve repair.

In this study, the authors find that ribonuclease 4 (RNase4)-expressing nociceptors, through RNase4, act as regulatory hubs that maintain peripheral nerve stability and coordinate nerve responses to injury, revealing a homeostatic role for nociceptors.

## Linked entities

- **Genes:** RNASE4 (ribonuclease A family member 4) [NCBI Gene 6038]

## Full-text entities

- **Genes:** Ehmt2 (euchromatic histone lysine N-methyltransferase 2) [NCBI Gene 110147] {aka Bat8, D17Ertd710e, G9a, KMT1C, NG36}, Prdm12 (PR domain containing 12) [NCBI Gene 381359] {aka Gm998}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Trpm8 (transient receptor potential cation channel, subfamily M, member 8) [NCBI Gene 171382] {aka CMR1, LTRPC6, LTrpC-6, TRPP8, Trp-p8}, Maz (MYC-associated zinc finger protein (purine-binding transcription factor)) [NCBI Gene 17188] {aka MAZI, PUR1, Pur-1, SAF-1, SAF-2}, Nefh (neurofilament, heavy polypeptide) [NCBI Gene 380684] {aka NF-H, NF200, Nfh, mKIAA0845}, Th (tyrosine hydroxylase) [NCBI Gene 21823], Calca (calcitonin/calcitonin-related polypeptide, alpha) [NCBI Gene 12310] {aka CA, CGRP-1, CGRP1, Calc, Calc1, Cgrp}, Eif2s1 (eukaryotic translation initiation factor 2, subunit 1 alpha) [NCBI Gene 13665] {aka 0910001O23Rik, 2410026C18Rik, 35kDa, Eif2a, eIF2alpha}, Scn8a (sodium channel, voltage-gated, type VIII, alpha) [NCBI Gene 20273] {aka C630029C19Rik, NaCh6, Nav1.6, dmu, med, mnd-2}, Pepb (peptidase B) [NCBI Gene 109628] {aka Pep-2, Pep2, Trip-1}, Ret (ret proto-oncogene) [NCBI Gene 19713] {aka PTC, RET51, RET9, c-Ret}, Rpl9 (ribosomal protein L9) [NCBI Gene 20005], Kank4 (KN motif and ankyrin repeat domains 4) [NCBI Gene 242553] {aka Ankrd38, C130031J23}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, Sox11 (SRY (sex determining region Y)-box 11) [NCBI Gene 20666] {aka 1110038H03Rik, 6230403H02Rik, end1}, Tac1 (tachykinin 1) [NCBI Gene 21333] {aka 4930528L02Rik, NK-1, NK1, Nkna, PPT-A, PPTA}, Ang (angiogenin, ribonuclease, RNase A family, 5) [NCBI Gene 11727] {aka Ang1, Rnase5, Rnase5a}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Mapt (microtubule-associated protein tau) [NCBI Gene 17762] {aka Mtapt, PHF-tau, Tau}, Rnase1 (ribonuclease, RNase A family, 1 (pancreatic)) [NCBI Gene 19752] {aka Rib-1, Rib1}, Kcnh8 (potassium voltage-gated channel, subfamily H (eag-related), member 8) [NCBI Gene 211468] {aka C130090D05Rik, ELK, ELK1, ELK3, Kv12.1}, Rbfox3 (RNA binding protein, fox-1 homolog (C. elegans) 3) [NCBI Gene 52897] {aka Fox-3, Hrnbp3, NeuN, Neuna60}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Syt9 (synaptotagmin IX) [NCBI Gene 60510], Rps27 (ribosomal protein S27) [NCBI Gene 57294] {aka 3200001M24Rik}, Trpv1 (transient receptor potential cation channel, subfamily V, member 1) [NCBI Gene 193034] {aka OTRPC1, TRPV1alpha, TRPV1beta, VR-1, Vr1}, Gspt1 (G1 to S phase transition 1) [NCBI Gene 14852] {aka G1st, Gst-1}, Trpc3 (transient receptor potential cation channel, subfamily C, member 3) [NCBI Gene 22065] {aka Mwk, Trcp3, Trp3, Trrp3}, Kcnf1 (potassium voltage-gated channel, subfamily F, member 1) [NCBI Gene 382571] {aka Gm1182, Kv5.1}, Rps10 (ribosomal protein S10) [NCBI Gene 67097] {aka 2210402A09Rik}, Pvalb (parvalbumin) [NCBI Gene 19293] {aka PV, Parv, Pva}, SST (somatostatin) [NCBI Gene 6750] {aka SMST, SST1}, Irf3 (interferon regulatory factor 3) [NCBI Gene 54131] {aka C920001K05Rik, IRF-3}, Rnase4 (ribonuclease, RNase A family 4) [NCBI Gene 58809] {aka C730049F20Rik, Rab1}, Ngf (nerve growth factor) [NCBI Gene 18049] {aka Ngfb, beta-NGF}, Cpeb3 (cytoplasmic polyadenylation element binding protein 3) [NCBI Gene 208922] {aka 4831444O18Rik, CPE-BP3, mKIAA0940}, Grik1 (glutamate receptor, ionotropic, kainate 1) [NCBI Gene 14805] {aka A830007B11Rik, D16Ium24, D16Ium24e, GluK1, GluK5, Glur-5}, Atf3 (activating transcription factor 3) [NCBI Gene 11910] {aka LRG-21}, Slc16a6 (solute carrier family 16 (monocarboxylic acid transporters), member 6) [NCBI Gene 104681] {aka ESTM12, MCT 6, MCT 7, MCT6}, Dync2h1 (dynein cytoplasmic 2 heavy chain 1) [NCBI Gene 110350] {aka 4432416O06Rik, D030010H02Rik, D330044F14Rik, DHC11, DHC1b, DHC2}, Tubd1 (tubulin, delta 1) [NCBI Gene 56427] {aka 4930550G19Rik, Tubd}, Mrpl4 (mitochondrial ribosomal protein L4) [NCBI Gene 66163] {aka 1110017G11Rik}, Kcng3 (potassium voltage-gated channel, subfamily G, member 3) [NCBI Gene 225030] {aka KV6.3, Kv10.1a, Kv10.1b}, Kctd1 (potassium channel tetramerisation domain containing 1) [NCBI Gene 106931] {aka 4933402K10Rik}, Tubb3 (tubulin, beta 3 class III) [NCBI Gene 22152] {aka 3200002H15Rik, M(beta)3, M(beta)6}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}, Sst (somatostatin) [NCBI Gene 20604] {aka SOM, SRIF, SS, Smst}, Trim27 (tripartite motif-containing 27) [NCBI Gene 19720] {aka Gm19403, Rfp}, Cndp2 (CNDP dipeptidase 2) [NCBI Gene 66054] {aka 0610010E05Rik, Cn2, Dip-2, Pep-1, Pep1}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Prph (peripherin) [NCBI Gene 19132] {aka Prph1}, Axl (AXL receptor tyrosine kinase) [NCBI Gene 26362] {aka Ark, Tyro7, Ufo}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Gm6710 (predicted gene 6710) [NCBI Gene 626832] {aka 1600017I02Rik, 2310011F05Rik, 2900089K14Rik, 3100002L24Rik, WF-4}, Trpa1 (transient receptor potential cation channel, subfamily A, member 1) [NCBI Gene 277328] {aka Anktm1, TRPA1b}, Ntrk1 (neurotrophic tyrosine kinase, receptor, type 1) [NCBI Gene 18211] {aka Tkr, TrkA, trk}, Zfp433 (zinc finger protein 433) [NCBI Gene 73610] {aka 1700123A16Rik}, RNASE4 (ribonuclease A family member 4) [NCBI Gene 6038] {aka RAB1, RNS4}
- **Diseases:** tissue injury (MESH:D017695), neuroblastoma (MESH:D009447), Wallerian degeneration (MESH:D014855), mechanical allodynia (MESH:D006930), inflammation (MESH:D007249), ALS (MESH:D000690), axonal degeneration (MESH:D009410), Sciatic nerve crush injury (MESH:D000071576), Sciatic nerve crush (MESH:D020426), chronic pain (MESH:D059350), demyelination (MESH:D003711), nerve injury (MESH:D000080902), Injury (MESH:D014947), neuropathic pain (MESH:D009437), Huntington's disease (MESH:D006816), neurodegenerative conditions (MESH:D019636), peripheral nerve injury (MESH:D059348), neuroinflammatory (MESH:D000090862), immune dysfunction (MESH:D007154), cardiovascular disorders (MESH:D002318), Pain (MESH:D010146)
- **Chemicals:** PBS (MESH:D007854), picric acid (MESH:C005858), TBS (MESH:D013725), corn oil (MESH:D003314), methanol (MESH:D000432), penicillin (MESH:D010406), H2O2 (MESH:D006861), DMSO (MESH:D004121), dichloromethane (MESH:D008752), sodium azide (MESH:D019810), phosphate (MESH:D010710), isoflurane (MESH:D007530), formaldehyde (MESH:D005557), AraC (MESH:D003561), glucose (MESH:D005947), TBS-T (MESH:C027647), fluorescein (MESH:D019793), Glycine (MESH:D005998), osmium tetroxide (MESH:D009993), DTT (MESH:D004229), LY294002 (MESH:C085911), TAM (MESH:D013629), Tween-20 (MESH:D011136), CO2 (MESH:D002245), glutaraldehyde (MESH:D005976), buprenorphine (MESH:D002047), sucrose (MESH:D013395), Wort (MESH:D000077191), L-glutamine (MESH:D005973), KCl (MESH:D011189), acetone (MESH:D000096), Rapa (MESH:D020123), dibenzyl ether (MESH:C076624), ethanol (MESH:D000431), Triton X-100 (MESH:D017830), 681676-1MG (-), carprofen (MESH:C007005), PVDF (MESH:C024865), streptomycin (MESH:D013307), uranyl acetate (MESH:C005460), LX-112 (MESH:C034564), MK-2206 (MESH:C548887), iodixanol (MESH:C044834), Potassium (MESH:D011188), SDS (MESH:D012967), MgCl2 (MESH:D015636), DAPI (MESH:C007293), capsaicin (MESH:D002211), heparin (MESH:D006493), paraformaldehyde (MESH:C003043), GlutaMAX (MESH:C054122)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G712A
- **Cell lines:** ND7/23 — Mus musculus (Mouse), Hybrid cell line (CVCL_4259)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13022371/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13022371/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC13022371/full.md

---
Source: https://tomesphere.com/paper/PMC13022371